Tirzepatide rewires appetite and slashes calorie intake in new obesity trial A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain imaging revealed that tirzepatide also lowered neural responses to high-fat, high-sugar food cues, offering mechanistic insight into its potent weight-loss effects.
https://www.news-medical.net/n....ews/20250625/Tirzepa